Le Lézard
Classified in: Health
Subjects: CHI, SVY

National Report: Washington Ranks 42nd in Protecting Kids from Tobacco


WASHINGTON, Dec. 13, 2017 /PRNewswire-USNewswire/ -- Washington ranks 42nd nationwide in funding programs that prevent kids from smoking and help smokers quit, according to a report released today by leading public health organizations. Washington is spending $1.4 million this year on tobacco prevention and cessation programs, which is just 2.2 percent of the $63.6 million recommended by the Centers for Disease Control and Prevention (CDC).

Campaign for Tobacco-Free Kids logo. (PRNewsFoto/Campaign for Tobacco-Free Kids)

The report challenges states to do more to fight tobacco use ? the nation's leading cause of preventable death ? and make the next generation tobacco-free. In Washington, 6.3 percent of high school students smoke, and 2,500 kids become regular smokers each year. Tobacco use claims 8,300 Washington lives and costs the state $2.8 billion in health care bills annually.

Other key findings in the report include:

The report ? "Broken Promises to Our Children: A State-by-State Look at the 1998 Tobacco Settlement 19 Years Later" ? was released by the Campaign for Tobacco-Free Kids, American Cancer Society Cancer Action Network, American Heart Association, American Lung Association, the Robert Wood Johnson Foundation, Americans for Nonsmokers' Rights and Truth Initiative.

Washington has been a leader in fighting tobacco with a high cigarette tax ($3.025 per pack) and a strong, statewide smoke-free law. But, Washington has drastically reduced its tobacco prevention program despite its role in reducing smoking and evidence that the program saved $5 in tobacco-related hospitalization costs for every $1 spent. In addition to restoring funding for tobacco prevention, health advocates are urging Washington lawmakers to increase the tobacco sale age to 21.

"While Washington has made progress in reducing smoking, the state's failure to adequately fund tobacco prevention and cessation programs is putting kids' health at risk and costing taxpayers more in tobacco-related health care costs," said Matthew L. Myers, President of the Campaign for Tobacco-Free Kids. "We can win the fight against tobacco and make the next generation tobacco-free, but Washington needs to do its part to help achieve these goals. Raising the state's tobacco age to 21 would be an excellent step forward."

The U.S. has reduced smoking to record lows ? 15.1 percent among adults and 8 percent among high school students. But tobacco use still kills more than 480,000 Americans and costs the nation about $170 billion in health care bills each year.

Today's report also highlights large disparities in who smokes and who suffers from tobacco-related diseases in the United States. Smoking rates are especially high in a swath of 12 states in the Midwest and South, an area called "Tobacco Nation" in a recent Truth Initiative report. Nationwide, smoking rates are highest among people who live below the poverty level and have less education, American Indians/Alaska Natives, LGBT Americans, those who are uninsured or on Medicaid, and those with mental illness. These differences are in large part due to the tobacco industry's targeting of vulnerable populations through advertising, price discounting and other marketing strategies.

By funding tobacco prevention and cessation programs at the CDC's recommended levels, states can reduce tobacco use among all Americans. But most states are falling far short:

The report and state-specific information can be found at tfk.org/statereport.

SOURCE Campaign for Tobacco-Free Kids


These press releases may also interest you

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...



News published on and distributed by: